News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,476 Results
Type
Article (5015)
Company Profile (17)
Press Release (220444)
Section
Business (82275)
Career Advice (462)
Deals (15056)
Drug Delivery (8)
Drug Development (19066)
Employer Resources (31)
FDA (3683)
Job Trends (3908)
News (120215)
Policy (7514)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (293)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14789)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3700)
Artificial intelligence (41)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2865)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (446)
Cardiovascular disease (24)
Career advice (394)
Career pathing (3)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16033)
Collaboration (169)
Compensation (169)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (104)
Cystic fibrosis (16)
Data (512)
Depression (5)
Diabetes (42)
Diagnostics (2042)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40855)
Editorial (2)
Employer branding (6)
Employer resources (32)
Events (37792)
Executive appointments (311)
FDA (3935)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (108)
Government (414)
Guidances (17)
Healthcare (5041)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7831)
IRA (3)
Job creations (1125)
Job search strategy (361)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2334)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (11)
Manufacturing (49)
MASH (28)
Medical device (3864)
Medtech (3865)
Mergers & acquisitions (7430)
Metabolic disorders (122)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (340)
NextGen: Class of 2025 (1676)
Non-profit (728)
Northern California (927)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (27)
Partnered (4)
Patents (21)
Patient recruitment (29)
Peanut (5)
People (24605)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4777)
Phase II (6963)
Phase III (5550)
Pipeline (553)
Policy (9)
Postmarket research (625)
Preclinical (1870)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1879)
Recruiting (8)
Regulatory (5122)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Southern California (700)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1009)
Stomach cancer (1)
Supply chain (11)
Tariffs (4)
United States (7036)
Vaccines (36)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Today (6)
Last 7 days (174)
Last 30 days (699)
Last 365 days (9954)
2025 (2994)
2024 (11035)
2023 (13203)
2022 (18691)
2021 (19728)
2020 (18270)
2019 (13216)
2018 (10208)
2017 (10018)
2016 (9173)
2015 (12136)
2014 (9598)
2013 (7713)
2012 (8337)
2011 (8801)
2010 (8638)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11455)
Australia (1608)
California (1943)
Canada (699)
China (71)
Colorado (82)
Connecticut (91)
Delaware (29)
Europe (24542)
Florida (275)
Georgia (33)
Idaho (23)
Illinois (113)
India (7)
Indiana (64)
Iowa (2)
Japan (72)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (222)
Massachusetts (1552)
Michigan (85)
Minnesota (139)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (558)
New Mexico (5)
New York (473)
North Carolina (327)
North Dakota (2)
Northern California (927)
Ohio (56)
Oklahoma (5)
Oregon (4)
Pennsylvania (345)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (700)
Tennessee (40)
Texas (228)
Utah (60)
Virginia (46)
Washington D.C. (9)
Washington State (174)
West Virginia (2)
Wisconsin (22)
225,476 Results for "steris corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025
April 23, 2025
·
7 min read
Press Releases
STERIS Announces Outcome of Ethylene Oxide Trial
January 21, 2025
·
7 min read
Press Releases
STERIS Declares Dividend of $0.57 per share
January 29, 2025
·
7 min read
Press Releases
STERIS Announces Financial Results for Fiscal 2025 Third Quarter
February 6, 2025
·
14 min read
Business
STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024.
May 8, 2024
·
17 min read
Press Releases
STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025
January 23, 2025
·
7 min read
Business
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 third quarter ended December 31, 2023.
February 7, 2024
·
14 min read
Press Releases
STERIS Announces Financial Results for Fiscal 2025 Second Quarter
November 7, 2024
·
14 min read
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
STERIS plc announced that the Company has entered into a definitive agreement to divest its Dental segment to Peak Rock Capital, a leading middle-market private investment firm, for $787.5 million.
April 11, 2024
·
9 min read
Business
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024.
April 24, 2024
·
8 min read
1 of 22,548
Next
